Assessing the Chemoprotective Effects of Short-Chain Fatty Acids on Mouse Colonic Organoid Growth and HDAC Activity

Introduction: Short-chain fatty acids (SCFAs) are metabolites produced by anaerobic bacteria inhabiting the colon when dietary fiber undergoes the process of fermentation. With butyrate comprising a majority of colonocyte energy requirements, SCFAs are important metabolic fuels. SCFAs, mainly butyrate and propionate, also act as epigenetic regulators as they function to inhibit histone deacetylase (HDAC) activity at high concentrations. Because butyrate and propionate can suppress cell proliferation and induce cell death, current studies seek to assess the protective effects of SCFAs in colorectal cancer and other metabolic diseases such as inflammatory bowel disease. However, the effects of SCFAs on intestinal stem cell biology have not been well studied to date in mouse colonic organoids. We hypothesize that organoids treated with high concentrations of butyrate and propionate will exhibit reduced growth and increased HDAC inhibition, consistent with the anti-cancer effects of SCFAs.

Objectives: Determine the effects of SCFAs on organoid growth and HDAC activity to assess the chemoprotective role of SCFAs in the mouse colon.

Methods: GFP-Lgr5+ stem cells from adult mouse colons were isolated, sorted, and treated with various concentrations of SCFAs (acetate, propionate, butyrate alone). Organoid-forming efficiency (stemness measurement) and organoid area (cell proliferation measurement) were assessed. HDAC activity was measured to assess the role of butyrate and propionate as HDAC inhibitors.

Results: Individual SCFAs promoted organoid-forming efficiency and organoid area dose dependently after 5 days of culture. However, organoids treated with high concentrations of butyrate or propionate exhibited reduced organoid growth. Analysis of HDAC activity in organoids treated with varying concentrations of butyrate or propionate also exhibited a biphasic dose response.

Conclusions: Our findings indicate that SCFAs, mainly butyrate and propionate, have chemoprotective effects as they modulate colonic organoid stem cell survival and cell proliferation in a dose-dependent manner. Findings from our organoid model will help elucidate the role of SCFAs as anti-cancer agents and illuminate the potential for dietary fiber as a nutritional approach in complementing colon cancer treatments.